top of page

CBG, The mother of Cannabinoids- The New CBD

Updated: Oct 6, 2020

What is CBG? Does it Work?

CBG is a phytocannabinoid that was discovered by Dr. Raphael Mechoulam, a chemist at the Weizman Institute in Israel, during the same time that his lab discovered THC and CBD in 1963-64.1 CBG is created from its acidic form, Cannabigerolic acid (CBGA), known as the mother of cannabinoids, because CBGa is responsible for the formation of THCa, CBDa, CBCa, and CBG.

CBG only occurs in small quantities, making it rare and expensive. The small quantity is due to the majority of CBGa being broken down into THCa and CBDa.2 CBG is non-psychotropic and binds primarily with CB2 receptors that are highly concentrated in our peripheral nervous system and immune system. CBG also works synergistically with other cannabinoids to enhance overall wellness and bring balance to our ECS demonstrated by the entourage effect.* The entourage effect was originally recognized by Dr. Raphael Mechoulam and Shimon Ben-Shabat when they discovered that “inactive” metabolites and related compounds increased the activity of endocannabinoids Anandamide and 2-AG.3

Further research by Dr. Ethan Russo, board-certified neurologist and Director of Research and Development for the International Cannabis and Cannabinoids Institute (ICCI), described the effect as a phenomenon where the cannabinoids and other related compounds work in a synergistic fashion leading to increased therapeutic benefits as compared to those seen from individual compounds.4What does this mean? Here’s a simple analogy:

Cannabinoids like CBG offer tremendous therapeutic support but, when taken together with other cannabinoids and compounds, they can better support your overall wellness and increase the balance of your ECS.* Full spectrum hemp-derived cannabinoid products offer all the beneficial terpenes, flavonoids, and other synergistic compounds that help support healthy body systems and help keep the body in balance.*

The combination of CBD and CBG contributes to a beneficial entourage effect as each cannabinoid offers its own support mechanism when interacting with the CB1 and CB2 receptors. CBG supports overall gut health and a healthy skin microbiome, and when used with CBD, delivers further therapeutic benefits because of the power the entourage effect can have.* Get CBG and try it, it works. To Buy CBD And CBG go to

What does the research say?

Even though the majority of people may be less familiar with CBG, its growing potential hasn’t escaped the researcher’s eye. We have been focused on CBD because we know if you get CBD it works. CBG was largely ignored for decades until recently. Studies show that CBG can potentiate effects throughout the ECS like CBD and THC. In one study, CBG was found to be helpful in the treatment of negative side effects of chemotherapy.5 As far back as the 1980s, animal research on CBG uncovered its support for overall eye health when administered regularly.6Another animal study published in 1996, evaluated CBG as a method to support normal, healthy cell growth.7 In 2013, research of CBG showed promise as a potential treatment of intestinal distress with the recommendation that human studies move forward.8 One of the very first human studies on CBG researched its effectiveness to help support appropriate levels of inflammatory compounds for healthy skin and additional support for the immune system.9 Researchers have also found that CBG offers support, not just in our immune system, but throughout many of our body’s systems.* Most notably, CBG helps support healthy digestion by stimulating appetite and helping to maintain a normal gut environment.* CBG has also been shown to support a healthy circulatory system10 normal, healthy bone growth,11 normal emotional health, and more.*

Ongoing research on CBG continues to uncover more and more of this amazing cannabinoid’s potential. Pharmaceutical companies are conducting research and filing patents on possible therapeutic benefits of CBG, two of which were filed in 2018 for studies related to inflammatory compounds, found in the skin and are related to keratinocytes (skin cells that produce keratin) and antiproliferative cell growth, respectively. GW Pharmaceuticals has also filed a patent on the uses of CBG in studies they have been and currently are conducting. See the full patent. Further studies report the potential neuroprotectant properties of CBG on the central and peripheral nervous systems.12,13,14In addition CBG has also been studied as a way to support healthy levels of inflammatory compounds and support normal bone growth and healing properties.*15

The future of CBG

The more we learn about the potential benefits of CBG and its role in the entourage effect, the more we see an uptick in CBG research and hemp-derived CBG products on the market. Even the U.S. Government, with The National Center for Complementary and Integrative Health (NCCIH), announced their intent to research CBG and its therapeutic potential for nociception management which started back in 2019.16 With each new study, we see the potential benefits for cannabinoids like CBG skyrocketing ever higher. Unlocking new information on the benefits of the entourage effect with the advantages from the combination of CBG and CBD is just the start for really understanding the balance our bodies strive for and the combination of cannabinoids that will help us achieve that homeostasis.

To Buy CBD or CBG today go to Hemp certified, 100% organic, 3rd party tested. We have bundled packages of CBD and CBG or you can purchase separately Get CBD it Works! try your 7 day trial. CBD or CBG , or both!

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, prevent or mitigate any disease or medical conditions.

[1] Mechoulam, R., & Hanuš, L. (2000). A historical overview of chemical research on cannabinoids. Chemistry and Physics of Lipids, 108(1-2), 1-13. doi:10.1016/s0009-3084(00)00184-5

[2] Meijer, E. P., & Hammond, K. M. (2005). The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plants. Euphytica, 145(1-2), 189-198. doi:10.1007/s10681-005-1164-8

[3] Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M., Vogel, Z., . . . Mechoulam, R. (1998). An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. European Journal of Pharmacology, 353(1), 23-31. doi:10.1016/s0014-2999(98)00392-6

[4] Russo, E. B. (2019). The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain. Frontiers in Plant Science, 9. doi:10.3389/fpls.2018.01969

[5] Brierley, D. I., Harman, J. R., Giallourou, N., Leishman, E., Roashan, A. E., Mellows, B. A., . . . Williams, C. M. (2019). Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol. Journal of Cachexia, Sarcopenia and Muscle, 10(4), 844-859. doi:10.1002/jcsm.12426

[6] Colasanti, B. K., Craig, C. R., & Allara, R. (1984). Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol. Experimental Eye Research, 39(3), 251-259. doi:10.1016/0014-4835(84)90013-7

[7] Baek, S., Du Han, S., Yook, C.N. et al. Synthesis and antitumor activity of cannabigerol. Arch. Pharm. Res. 19, 228–230 (1996).

[8] Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., . . . Izzo, A. A. (2013). Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease [Abstract]. Biochemical Pharmacology, 85(9), 1306-1316. doi:10.1016/j.bcp.2013.01.017

[9] Wilkinson, J. D., & Williamson, E. M. (2007). Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. Journal of Dermatological Science, 45(2), 87-92. doi:10.1016/j.jdermsci.2006.10.009

[10] Hazekamp, A., Fischedick, J. T., Díez, M. L., Lubbe, A., & Ruhaak, R. L. (2010). Chemistry of Cannabis. Comprehensive Natural Products II, 3, 1033-1084. doi:10.1016/b978-008045382-8.00091-5

[11] Baek, S., Du Han, S., Yook, C.N. et al. Synthesis and antitumor activity of cannabigerol. Arch. Pharm. Res. 19, 228–230 (1996).

[12] Valdeolivas, S., Navarrete, C., Cantarero, I. et al. Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice. Neurotherapeutics 12, 185–199 (2015).

[13] García, C., Gómez-Cañas, M., Burgaz, S. et al. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor. J Neuroinflammation 15, 19 (2018).

[14] Rodríguez-Cueto, C., Santos-García, I., García-Toscano, L., Espejo-Porras, F., Bellido, M., Fernández-Ruiz, J., . . . Lago, E. D. (2018). Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis. Biochemical Pharmacology, 157, 217-226. doi:10.1016/j.bcp.2018.07.049

[15] Andre, C. M., Hausman, J. F., & Guerriero, G. (2016). Cannabis sativa: The Plant of the Thousand and One Molecules. Frontiers in plant science, 7, 19.

[16] National Center for Complementary and Integrative Health (NCCIH). (2018, November). Notice of Intent to Publish a Funding Opportunity Announcement for Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21, Clinical Trial Optional) [Press release]. Retrieved July 7, 2020, from

4 views0 comments

Recent Posts

See All
bottom of page